Company
Last deal
$20M
Amount
Post-IPO Equity
Stage
28.06.2024
Date
13
all rounds
$218.4M
Total amount
General
About Company
Allurion Technologies develops a non-surgical, swallowable gastric balloon for weight loss.
Industry
Sector :
Subsector :
Keywords :
Also Known As
Elipse, SGL Medical, Allurion Technologies Holdings, Inc.
founded date
01.01.2009
Number of employees
Company Type
For Profit
Last funding type
Post-IPO Equity
IPO status
Private
Contacts
Phone number
Website URL